Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer | MicrobiomeTrials
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-05-15Est. Completion: 2028-03-19
Enrollment target: 40 participants
Locations
City of Hope National Medical Center, Duarte, California, United States
City of Hope Lennar Foundation Cancer Center, Irvine, California, United States
Hope and Healing Clinical Research, Hinsdale, Illinois, United States
Hope and Healing Clinical Research, New Lenox, Illinois, United States
Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China
Shanghai Chest Hospital, Shanghai, Shanghai Municipality, China
Sheba Medical Center, Ramat Gan, HA Merkaz, Israel
Shaare Zedek Medical Center, Jerusalem, Jerusalem, Israel
Japanese Foundation for Cancer Research, Kotoku, Tokyo, Japan
National Cheng Kung University Hospital, Tainan, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
Contact
Other microbiome trials you might be interested in